N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure

Data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study

G. Michael Felker, David Whellan, William E. Kraus, Robert Clare, Faiez Zannad, Mark Donahue, Kirkwood Adams, Robert McKelvie, Ileana L. Pina, Christopher M. O'Connor

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Objectives: To examine the relationship between N-terminal pro-brain natriuretic peptide (NT-proBNP) and exercise capacity in a large contemporary cohort of patients with chronic heart failure. Background: Natriuretic peptides such as NT-proBNP are important biomarkers in heart failure. The relationship between NT-proBNP and exercise capacity has not been well studied. Methods: We analyzed the relationship between baseline NT-proBNP and peak oxygen uptake (peak Vo2) or distance in the 6-minute walk test in 1383 subjects enrolled in the HF-ACTION study. Linear regression models were used to analyze the relationship between NT-proBNP and peak Vo2 or distance in the 6-minute walk test in the context of other clinical variables. Receiver operator curve analysis was used to evaluate the ability of NT-proBNP to accurately predict a peak Vo2 <12 mL/kg per minute. Results: NT-proBNP was the most powerful predictor of peak Vo2 (partial R2 = 0.13, P < .0001) of 35 candidate variables. Although NT-proBNP was also a predictor of distance in the 6-minute walk test, this relationship was weaker than that for peak Vo2 (partial R2 = 0.02, P < .0001). For both peak Vo2 and distance in the 6-minute walk test, much of the variability in exercise capacity remained unexplained by the variables tested. Receiver operator curve analysis suggested NT-proBNP had moderate ability to identify patients with peak Vo2 <12 mL/kg per minute (c-index, 0.69). Conclusions: In this analysis of baseline data from HF-ACTION, NT-proBNP was the strongest predictor of peak Vo2 and a significant predictor of distance in the 6-minute walk test. Despite these associations, NT-proBNP demonstrated only modest performance in identifying patients with a low peak Vo2 who might be considered for cardiac transplantation. These data suggest that, although hemodynamic factors are important determinants of exercise capacity, much of the variability in exercise performance in heart failure remains unexplained by traditional clinical and demographic variables.

Original languageEnglish (US)
JournalAmerican Heart Journal
Volume158
Issue number4 SUPPL.
DOIs
StatePublished - Oct 2009
Externally publishedYes

Fingerprint

Brain Natriuretic Peptide
Heart Failure
Exercise
Linear Models
Natriuretic Peptides
Heart Transplantation
Biomarkers
Hemodynamics
Demography
Walk Test
Oxygen

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure : Data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study. / Felker, G. Michael; Whellan, David; Kraus, William E.; Clare, Robert; Zannad, Faiez; Donahue, Mark; Adams, Kirkwood; McKelvie, Robert; Pina, Ileana L.; O'Connor, Christopher M.

In: American Heart Journal, Vol. 158, No. 4 SUPPL., 10.2009.

Research output: Contribution to journalArticle

Felker, G. Michael ; Whellan, David ; Kraus, William E. ; Clare, Robert ; Zannad, Faiez ; Donahue, Mark ; Adams, Kirkwood ; McKelvie, Robert ; Pina, Ileana L. ; O'Connor, Christopher M. / N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure : Data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study. In: American Heart Journal. 2009 ; Vol. 158, No. 4 SUPPL.
@article{c94c34dc4b1745bb9ae30ccbc2cc3c42,
title = "N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: Data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study",
abstract = "Objectives: To examine the relationship between N-terminal pro-brain natriuretic peptide (NT-proBNP) and exercise capacity in a large contemporary cohort of patients with chronic heart failure. Background: Natriuretic peptides such as NT-proBNP are important biomarkers in heart failure. The relationship between NT-proBNP and exercise capacity has not been well studied. Methods: We analyzed the relationship between baseline NT-proBNP and peak oxygen uptake (peak Vo2) or distance in the 6-minute walk test in 1383 subjects enrolled in the HF-ACTION study. Linear regression models were used to analyze the relationship between NT-proBNP and peak Vo2 or distance in the 6-minute walk test in the context of other clinical variables. Receiver operator curve analysis was used to evaluate the ability of NT-proBNP to accurately predict a peak Vo2 <12 mL/kg per minute. Results: NT-proBNP was the most powerful predictor of peak Vo2 (partial R2 = 0.13, P < .0001) of 35 candidate variables. Although NT-proBNP was also a predictor of distance in the 6-minute walk test, this relationship was weaker than that for peak Vo2 (partial R2 = 0.02, P < .0001). For both peak Vo2 and distance in the 6-minute walk test, much of the variability in exercise capacity remained unexplained by the variables tested. Receiver operator curve analysis suggested NT-proBNP had moderate ability to identify patients with peak Vo2 <12 mL/kg per minute (c-index, 0.69). Conclusions: In this analysis of baseline data from HF-ACTION, NT-proBNP was the strongest predictor of peak Vo2 and a significant predictor of distance in the 6-minute walk test. Despite these associations, NT-proBNP demonstrated only modest performance in identifying patients with a low peak Vo2 who might be considered for cardiac transplantation. These data suggest that, although hemodynamic factors are important determinants of exercise capacity, much of the variability in exercise performance in heart failure remains unexplained by traditional clinical and demographic variables.",
author = "Felker, {G. Michael} and David Whellan and Kraus, {William E.} and Robert Clare and Faiez Zannad and Mark Donahue and Kirkwood Adams and Robert McKelvie and Pina, {Ileana L.} and O'Connor, {Christopher M.}",
year = "2009",
month = "10",
doi = "10.1016/j.ahj.2009.07.011",
language = "English (US)",
volume = "158",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "4 SUPPL.",

}

TY - JOUR

T1 - N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure

T2 - Data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study

AU - Felker, G. Michael

AU - Whellan, David

AU - Kraus, William E.

AU - Clare, Robert

AU - Zannad, Faiez

AU - Donahue, Mark

AU - Adams, Kirkwood

AU - McKelvie, Robert

AU - Pina, Ileana L.

AU - O'Connor, Christopher M.

PY - 2009/10

Y1 - 2009/10

N2 - Objectives: To examine the relationship between N-terminal pro-brain natriuretic peptide (NT-proBNP) and exercise capacity in a large contemporary cohort of patients with chronic heart failure. Background: Natriuretic peptides such as NT-proBNP are important biomarkers in heart failure. The relationship between NT-proBNP and exercise capacity has not been well studied. Methods: We analyzed the relationship between baseline NT-proBNP and peak oxygen uptake (peak Vo2) or distance in the 6-minute walk test in 1383 subjects enrolled in the HF-ACTION study. Linear regression models were used to analyze the relationship between NT-proBNP and peak Vo2 or distance in the 6-minute walk test in the context of other clinical variables. Receiver operator curve analysis was used to evaluate the ability of NT-proBNP to accurately predict a peak Vo2 <12 mL/kg per minute. Results: NT-proBNP was the most powerful predictor of peak Vo2 (partial R2 = 0.13, P < .0001) of 35 candidate variables. Although NT-proBNP was also a predictor of distance in the 6-minute walk test, this relationship was weaker than that for peak Vo2 (partial R2 = 0.02, P < .0001). For both peak Vo2 and distance in the 6-minute walk test, much of the variability in exercise capacity remained unexplained by the variables tested. Receiver operator curve analysis suggested NT-proBNP had moderate ability to identify patients with peak Vo2 <12 mL/kg per minute (c-index, 0.69). Conclusions: In this analysis of baseline data from HF-ACTION, NT-proBNP was the strongest predictor of peak Vo2 and a significant predictor of distance in the 6-minute walk test. Despite these associations, NT-proBNP demonstrated only modest performance in identifying patients with a low peak Vo2 who might be considered for cardiac transplantation. These data suggest that, although hemodynamic factors are important determinants of exercise capacity, much of the variability in exercise performance in heart failure remains unexplained by traditional clinical and demographic variables.

AB - Objectives: To examine the relationship between N-terminal pro-brain natriuretic peptide (NT-proBNP) and exercise capacity in a large contemporary cohort of patients with chronic heart failure. Background: Natriuretic peptides such as NT-proBNP are important biomarkers in heart failure. The relationship between NT-proBNP and exercise capacity has not been well studied. Methods: We analyzed the relationship between baseline NT-proBNP and peak oxygen uptake (peak Vo2) or distance in the 6-minute walk test in 1383 subjects enrolled in the HF-ACTION study. Linear regression models were used to analyze the relationship between NT-proBNP and peak Vo2 or distance in the 6-minute walk test in the context of other clinical variables. Receiver operator curve analysis was used to evaluate the ability of NT-proBNP to accurately predict a peak Vo2 <12 mL/kg per minute. Results: NT-proBNP was the most powerful predictor of peak Vo2 (partial R2 = 0.13, P < .0001) of 35 candidate variables. Although NT-proBNP was also a predictor of distance in the 6-minute walk test, this relationship was weaker than that for peak Vo2 (partial R2 = 0.02, P < .0001). For both peak Vo2 and distance in the 6-minute walk test, much of the variability in exercise capacity remained unexplained by the variables tested. Receiver operator curve analysis suggested NT-proBNP had moderate ability to identify patients with peak Vo2 <12 mL/kg per minute (c-index, 0.69). Conclusions: In this analysis of baseline data from HF-ACTION, NT-proBNP was the strongest predictor of peak Vo2 and a significant predictor of distance in the 6-minute walk test. Despite these associations, NT-proBNP demonstrated only modest performance in identifying patients with a low peak Vo2 who might be considered for cardiac transplantation. These data suggest that, although hemodynamic factors are important determinants of exercise capacity, much of the variability in exercise performance in heart failure remains unexplained by traditional clinical and demographic variables.

UR - http://www.scopus.com/inward/record.url?scp=70349291225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349291225&partnerID=8YFLogxK

U2 - 10.1016/j.ahj.2009.07.011

DO - 10.1016/j.ahj.2009.07.011

M3 - Article

VL - 158

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 4 SUPPL.

ER -